FDA Inspection 1209762 — Mehmet Ali Sendur
The FDA completed an inspection of Mehmet Ali Sendur on June 9, 2023 in Cankaya. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cankaya (Turkey)
Additional Details
Clinical BA/BE